"That’s a young population of women of childbearing age where you really wouldn’t expect a great many of these myocardial perfusion imaging studies to be done," Dr. Cerqueira commented.
He noted that the ASNC recommendations urge reserving myocardial perfusion imaging for patients in whom it has the greatest clinical utility: those at intermediate risk of coronary artery disease, patients requiring prognostic or management information, and those with persistent unexplained symptoms.
Dr. DePuey disclosed that he serves as an adviser to UltraSPECT and Dogwood Pharmaceuticals. The other speakers declared having no relevant financial interests.